1. Home
  2. KRMD vs HLN Comparison

KRMD vs HLN Comparison

Compare KRMD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$3.24

Market Cap

192.5M

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

BUY

Current Price

$9.31

Market Cap

42.8B

ML Signal

BUY

Company Overview

Basic Information
Metric
KRMD
HLN
Founded
1980
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
192.5M
42.8B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRMD
HLN
Price
$3.24
$9.31
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$6.50
N/A
AVG Volume (30 Days)
168.2K
12.5M
Earning Date
05-06-2026
02-26-2026
Dividend Yield
N/A
1.94%
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
$41,127,366.00
N/A
Revenue This Year
$20.32
$6.55
Revenue Next Year
$17.37
$4.42
P/E Ratio
N/A
$49.05
Revenue Growth
22.23
N/A
52 Week Low
$3.09
$8.65
52 Week High
$6.61
$11.28

Technical Indicators

Market Signals
Indicator
KRMD
HLN
Relative Strength Index (RSI) 39.58 38.96
Support Level $3.18 $9.08
Resistance Level $3.43 $10.20
Average True Range (ATR) 0.11 0.15
MACD 0.03 -0.04
Stochastic Oscillator 42.93 17.73

Price Performance

Historical Comparison
KRMD
HLN

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: